Fibroblast transgelin and smooth muscle SM22α are the same protein, the expression of which is down-regulated in many cell lines

Cell Motility and the Cytoskeleton

Volumn 38, Issue 3, 1997, Pages 250-257

  Lawson, Durward ^a   Harrison, Maureen ^b   Shapland, Claire ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Actin associated protein; Cell lines; Cytoskeleton; Transgelin; Tumourigenesis

Indexed keywords

ACTIN; CALCIUM ION; COMPLEMENTARY DNA; TRANSGELIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; DNA SEQUENCE; EMBRYO; EMBRYO DEVELOPMENT; FIBROBLAST; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CALCIUM; CELL LINE; CELL SURVIVAL; DOWN-REGULATION; FIBROBLASTS; IMMUNOBLOTTING; MICE; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; RATS; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 0030781498     PISSN: 08861544     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0169(1997)38:3<250::AID-CM3>3.0.CO;2-9     Document Type: Article

References (54)

1. Aaronson, S.A., and Todaro, G.J. (1968a): Basis for the acquisition of malignant potential by mouse cells cultivated in vitro. Science 162:1024-1026.
2. Aaronson, S.A., and Todaro, G.J. (1968b): Development of 3T3-like lines from Balb/c mouse embryo cultures: Transformation susceptibility to SV40. J. Cell Phys. 72:141-148.
3. Abercrombie, M., and Heaysman, J.E.M. (1976): Invasive behaviour between sarcoma and fibroblast populations in cell culture. J. Natl. Cancer Inst. 56:561-570.
4. Ben-Ze'ev, A. (1985): Cell shape, the complex cellular networks and gene expression: Cytoskeletal protein genes as a model system. Cell Muscle Motil. 6:23-53.
5. Ben-Ze'ev, A. (1986): Regulation of cytoskeletal protein synthesis in normal and cancer cells. Cancer Rev. 4:91-116.
6. Button, E., Shapland, C., and Lawson, D. (1995): Actin, its associated proteins and metastasis. Cell Motil. Cytoskeleton 30:247-251.
7. Chen, W.T. (1989): Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J. Exp. Zool. 251:167-185.
8. Fatigati, V., and Murphy, R.A. (1984): Actin and tropomyosin variants in smooth muscles. Dependence on tissue type. J. Biol. Chem. 259:14383-14388.
9. Felice, G.R., Eason, P., Nermut, M.V., and Kellie, S. (1990): pp 60 v-src association with the cytoskeleton induces actin reorganization without affecting polymerization status. Eur. J. Cell Biol. 52:47-59.
10. Franke, R.P., Grafe, M., Schnittler, H., Seiffge, D., and Mittermayer, E. (1984): Induction of human vascular endothelial stress fibres by fluid shear stress. Nature 307:648-649.
11. Genini, M., Schwalbe, P., Scholl, F.A., and Schafer, B.W. (1996): Isolation of genes differentially expressed in human primary myoblasts and embryonal rhabdomyosarcoma. Int. J. Cancer 66:571-577.
12. Gowing, L.R., Tellam, R.L., and Banyard, M.R.C. (1985): Actin synthesis in tumourgenic and non-tumourgenic human cells. J. Cell Sci. 76:255-267.
13. Heacock, C.S., Eidsvoog, K.E., and Bamburg, J.R. (1984): The influence of contact-inhibited growth and of agents which alter cell morphology on the levels of G and F actin in cultured cells. Exp. Cell Res. 153:402-412.
14. Henry, K. (1992): The thymus gland. In Henry, K., and Symmers, W.St.C. (eds.): "Thymus, Lymph Nodes, Spleen and Lymphatics." Churchill, Livingstone, London, pp. 27-139.
15. Jainchill, J.L., Aaronson, S.A., and Todaro, G.J. (1969): Murine sarcoma and leukemia viruses: Assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4:549-553.
16. Janmey, P.A., and Chaponnier, C. (1995): Medical aspects of the actin cytoskeleton. Curr. Opin. Cell Biol. 7:111-117.
17. Kemp, P.R., Osbourn, J.K., Grainger, D.J., and Metcalfe, J.C. (1995): Cloning and analysis of the promoter region of the rat SM22 a gene. Biochem. J. 310:1037-1043.
18. Kobayashi, R., Kubota, T., and Hidaka, H. (1994): Purification, characterization and partial sequence analysis of a new 25 kDa actin-binding protein from bovine aorta: A SM22 homolog. Biochem. Biophys. Res. Commun. 198:1275-1280.
19. Lawson, D. (1984): Distribution of epinemin in colloidal gold-labelled, quick-frozen, deep-etched cytoskeletons. J. Cell Biol. 99:1451-1460.
20. Lawson, D. (1987): Distribution of myosin and relationship to actin organization in cortical and subcortical areas of antibody-labelled, quick-frozen, deep-etched fibroblast cytoskeletons. Cell Motil. Cytoskeleton 7:368-380.
21. Leavitt, J., Gunning, P., Viedes, L., and Jariwalla, R. (1985): Smooth muscle α actin is a transformation-sensitive marker for mouse NIH 3T3 and Rat-2 cells. Nature 316:840-842.
22. Lees-Millar, J.P., Heeley, D.H., Smillie, L.B., and Kay, C.M. (1987): Isolation and characterization of an abundant and novel 22 kDa protein (SM22 α) from chicken gizzard smooth muscle. J. Biol. Chem. 262:2988-2993.
23. Lewis, L., Verna, J.M., Levinstone, D., Shar, S., Marek, L., and Bell, E. (1982): The relationship of fibroblast translocations to cell morphology and stress fibre density. J. Cell Sci. 53:21-36.
24. Li, L., Miano, J.M., Cserjesi, P., and Olson, E.N. (1996a): SM 22 α, a marker of adult smooth muscle is expressed in multiple myogenic lineages during embryogenesis. Circ. Res. 78:188-195.
25. Li, L., Miano, J.M., Mercer, B., and Olson, E.N. (1996b): Expression of the SM 22 α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J. Cell Biol. 132:849-859.
26. 45Ca autoradiography on nitrocellulose membrane after sodium dodecyl sulfate gel electrophoresis. J. Biochem. 95:511-519.
27. Mueller, S.C., Yeh, Y., and Chen, W.T. (1992): Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J. Cell Biol. 119:1309-1325.
28. Osbourn, J.K., Weissberg, P.L., and Shanahan, C.M. (1995): A regulatory element downstream of the rat SM22 α transcription start point enhances reporter gene expression in vascular smooth muscle cells. Gene 154:249-253.
29. Parish, R.W., Schmidhauser, C., Schmidt, T., and Dudler, R.K. (1987): Mechanisms of tumour cell metastasis. J. Cell Sci (Suppl) 8:181-197.
30. Plantfarber, L.C., and Hynes, R.O. (1989): Changes in integrin receptors on oncogenically transformed cells. Cell 56:281-290.
31. Pokorna, E., Jordan, P.W., O'Neill, C.H., Zicha, D., Gilbert, C.S., and Vesely, P. (1994): Actin cytoskeleton and motility in rat sarcoma cell populations with different metastatic potential. Cell Motil. Cytoskeleton 28:25-33.
32. Pollack, R., and Rifkin, D. (1975): Actin-containing cables within anchorage-dependent rat embryo cells are dissociated by plasmin and trypsin. Cell 6:495-506.
33. Pollack, R., Osborn, M., and Weber, K. (1975): Patterns of organization of actin and myosin in normal and transformed cells. Proc. Natl. Acad. Sci. U.S.A. 72:994-998.
34. Prinjha, R.K., Shapland, C.E., Hsuan, J.J., Totty, N.F., Mason, I.J., and Lawson, D. (1994): Cloning and sequencing of cDNAs, encoding the actin cross-linking protein transgelin defines a new family of actin-associated proteins. Cell Motil. Cytoskeleton 28:243-255.
35. Puck, T.T., and Krystosek, A. (1992): Role of the cytoskeleton in genome regulation and cancer. Int. Rev. Cytol. 132:75-109.
36. Rodriguez Fernandez, J.L., Geiber, B., Salomon, D., Sabanay, I., Zoller, M., and Ben-Ze'ev, A. (1992): Suppression of tumourgenicity in transformed cells after transfection by vinculin cDNA. J. Cell Biol. 119:427-438.
37. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989): "Molecular Cloning: A Laboratory Manual," 2nd ed. Cold Spring Harbor, N.Y.: Cold Spring Harbour Laboratory Press.
38. Sanford, K.K., Likely, G.D., and Earle, W.R. (1954): The development of variations in transplantability and morphology within a clone of mouse fibroblasts transformed to sarcoma producing cells in vitro. J. Natl. Cancer Inst. 15:215-237.
39. Shanahan, C.M., Weissberg, P.L., and Metcalfe, J.C. (1993): Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ. Res. 73:193-204.
40. Shapland, C., Lowings, P., and Lawson, D. (1988): Identification of new actin-associated polypeptides that are modified by viral transformation and changes in cell shape. J. Cell. Biol. 107:153-161.
41. Shapland, C., Hsuan, J.J., Totty, N.F., and Lawson, D. (1993): Purification and properties of transgelin a transformation and shape change sensitive actin gelling protein. J. Cell. Biol. 121:1065-1073.
42. Shin, S.I., Freedman, V.H., Risser, R., and Pollack, R. (1975): Tumourigenicity of virus-transformed nude mice is correlated specifically with anchorage independent growth in vitro. Proc. Natl. Acad. Sci. U.S.A. 72:4435-4439.
43. Solway, J., Seltzer, J., Samaha, F.F., Kim, S., Alger, L.E., Niu, O., Morrisey, E.E., Ip, H.S., and Parmacek, M.S. (1995): Structure and expression of a smooth muscle cell-specific gene SM22 α. J. Biol. Chem. 270:13460-13469.
44. Stossel, T.P. (1993): On the crawling of animal cells. Science 260:1086-1094.
45. Thweatt, R., Lumpkin, Jr. C.K., and Goldstein, S. (1992): A novel gene encoding a smooth muscle protein is overexpressed in senescent human fibroblasts. Biochem. Biophys. Res. Commun. 187:1-7.
46. Todaro, G.J., and Green, H. (1963): Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell. Biol. 17:299-313.
47. Topp, W.C. (1981): Normal rat cell lines deficient in nuclear thymidine kinaze. Virology 113:408-411.
48. Trofatter, J.A., MacCollin, M.M., Rutter, J.L., Murrell, J.R., Duyao, M.P., Parry, D.M., Eldridge, R., Kiley, N., Menon, A.G., Pulsaki, V., Haase, V.H., Ambrose, C.M., Munroe, D., Bove, C., Haines, J.L., Martuza, R.L., MacDonald, M.E., Seizinger, B.R., Short, M.P., Buckler, A.J., and Gusella, J.F. (1993): A novel moesin-ezrin-radixin-like gene is a candidate for the neurofibromatosis 2 tumour suppressor. Cell 72:791-800.
49. Tsukita, S., Itoh, M., Nagafachi, A., Yonemura, S., and Tsukita, S. (1993): Submembranous functional plaque proteins include potential tumour suppressor molecules. J. Cell. Biol. 123:1049-1053.
50. Turner, C.E. (1994): Paxillin: A cytoskeletal target for tyrosine kinases. Bioessays 16:47-51.
51. Van Roy, F., and Mareel, M. (1992): Tumour invasion: Effects of cell adhesion and motility. Trends Cells Biol. 2:163-169.
52. Verderame, M., Alcorta, D., Egnor, M., Smith, K., and Pollack, R. (1980): Cytoskeletal F actin patterns quantified with fluorescein isothiocyanate-phalloidin in normal and transformed cells. Proc. Natl. Acad. Sci. U.S.A. 77:6624-6628.
53. Wittelsberger, S.C., Kleene, K., and Penman, S. (1981): Progressive loss of shape-responsive metabolic controls in cells with increasingly transformed phenotype. Cell 24:859-866.
54. Wong, A.J., Pollard, T.D., and Herman, I.M. (1983): Actin filament stress fibres in vascular endothelial cells in vivo. Science 219:867-869.